Antibiotics (ABs) are among the most used pharmaceutical drugs worldwide, as they are currently the most effective medicines ...

To investigate the use of celecoxib on disease-free survival in patients with stage 3 colon cancer, Meyerhardt and colleagues initiated a randomized clinical trial, the CALGB (Alliance)/SWOG 80702 ...

Colonoscopy is at the heart of gastroenterology. It is a diagnostic and therapeutic tool and it has become the central figure in the crusade against colorectal cancer. Seven gastroenterologists ...

Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence is lacking. In this phase 3, randomized trial conducted at 55 centers, we ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their ...

A new clinical trial suggests magnesium supplements may boost gut bacteria that help block the development of colon cancer – but only for some people, depending on their genes and sex. An increase in ...

In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took GLP-1 ...

The American Gastroenterological Association (AGA) released a new clinical guideline making no recommendation — for or against — the use of computer-aided detection systems (CADe) in colonoscopy. A ...

Please provide your email address to receive an email when new articles are posted on . Patients with stage III deficient mismatch repair colon cancer derived significant benefit from the addition of ...

Colon cancer remains one of the most prevalent yet often undetected forms of cancer, developing silently in the large intestine. According to recent medical data, it ranks as the third most common ...